November 2022
171 articles-
Nov 28 · 01:49Bio Business News
Gene therapy biotech AGTC jumps on Syncona $23.5M bid to escape 'challenging' funding landscape
-
Nov 24 · 21:49Market Watch
FinnCap, Panmure Gordon End Takeover Discussions
-
Nov 24 · 01:39Biotechnology Daily
Oxford Nanopore debuts portable version of its high-throughput DNA sequencer
-
Nov 24 · 01:37Biotechnology Daily
Nicotine-nomming gut bacteria could protect against NASH
-
Nov 24 · 01:35Biotechnology Daily
Medtronic scores FDA approval for pacemaker hardware that taps into heart's natural electrical signals
-
Nov 24 · 01:34Biotechnology Daily
SPAC in fashion: Cancer-focused Aum is latest biotech to use blank check route
-
Nov 24 · 01:32Bio Business News
Sumitomo nets Myovant in $2.9B buyout, adding IVF asset to pipeline
-
Nov 24 · 01:19Bio Business News
Altamira finds buyer for Zilentin inner ear unit so Swiss biotech can go all-in on RNA
-
Nov 24 · 01:18Bio Business News
Novartis, eyeing $3B market, beats AstraZeneca blood disorder blockbusters in phase 3
-
Nov 24 · 01:17Bio Business News
New Philips CEO Jakobs apologizes for the 'pain' caused by sleep apnea device recalls
-
Nov 22 · 23:28Biotechnology Daily
Summit makes case for changes to antibiotic R&D after sharing data from failed phase 3 trial
-
Nov 22 · 23:27Biotechnology Daily
Gilead's Kite ties itself to Refuge's gene expression platform in blood cancer CAR-T deal
-
Nov 22 · 23:26Biotechnology Daily
FDA clears Intelligent Ultrasound's AI for real-time guidance in nerve block injections
-
Nov 22 · 23:24Biotechnology Daily
NIH study finds Black patients receive end-stage heart failure treatments at half the rate of white patients
-
Nov 22 · 23:23Bio Business News
Dreaded 'high placebo rate' hits Immunic's psoriasis trial, causing investors to flee
-
Nov 22 · 23:21Bio Business News
With $255M antibody biotech buy, AbbVie spies opportunity to take on tricky GPCRs
-
Nov 22 · 23:20Bio Business News
Prime time for IPO as gene editing biotech goes public with $175M
-
Nov 22 · 23:18Bio Business News
Cordis to absorb drug-eluting balloon maker MedAlliance for $235M upfront
-
Nov 22 · 06:58Biotechnology Daily
Talaris restarts transplant trial with assurance the reasons behind patient death won't reoccur
-
Nov 22 · 06:56Biotechnology Daily
AM-Pharma, once a Pfizer takeover target, flunks phase 3 kidney injury trial
-
Nov 22 · 06:55Biotechnology Daily
ACRO unveils Q&A toolkit to speed adoption of decentralized clinical trials
-
Nov 22 · 06:53Biotechnology Daily
Mouth microbe migrates pancreatic cancer cells
-
Nov 22 · 06:52Bio Business News
CRL opens UK plasmid facility, inks collaboration deal with Nanoscope
-
Nov 22 · 06:50Bio Business News
Veeva inks deals with 40 CROs, expanding digital clinical trial reach